Using nuclear envelope mutations to explore age-related skeletal muscle weakness
Edmund Battey1,2, Matthew J Stroud2, Julien Ochala1,3,4
1Centre of Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King's College London, London, SE1 1UL, U.K.
Clinical Science (London, England : 1979)
|August 27, 2020
Summary
Mutations in nuclear envelope proteins cause premature aging and muscle dysfunction. Understanding these genes may explain age-related skeletal muscle weakness.
Area of Science:
- Molecular Biology
- Gerontology
- Genetics
Background:
- Skeletal muscle weakness is a key factor in age-related loss of independence.
- The causes of age-related muscle weakness are not fully understood.
- Accelerated aging syndromes, like Hutchinson-Gilford Progerin Syndrome, offer insights into normal aging.
Purpose of the Study:
- To review the structure and function of nuclear envelope proteins.
- To explore how mutations in these proteins lead to premature aging and muscle pathologies.
- To highlight the potential role of nuclear envelope genes in age-related muscle weakness.
Main Methods:
- Literature review of genetic defects affecting nuclear envelope proteins.
- Analysis of mechanisms linking nuclear envelope protein mutations to disease.
- Examination of studies on accelerated aging syndromes and muscular dystrophies.
Main Results:
- Nuclear envelope protein defects are implicated in various premature aging and muscle diseases.
- Mutations can disrupt nuclear structure, leading to cellular dysfunction.
- These genetic disorders share common pathways with normal aging processes.
Conclusions:
- Nuclear envelope proteins are crucial for maintaining muscle health.
- Understanding these proteins and their mutations can illuminate the mechanisms of age-related muscle decline.
- Targeting nuclear envelope protein pathways may offer therapeutic strategies for age-related muscle weakness.
